Final results of a phase I study evaluating INVAC-1, a novel DNA vaccine expressing an inactive form of human telomerase reverse transcriptase (hTERT) in patients with advanced solid tumors.

Affiliation auteurs!!!! Error affiliation !!!!
TitreFinal results of a phase I study evaluating INVAC-1, a novel DNA vaccine expressing an inactive form of human telomerase reverse transcriptase (hTERT) in patients with advanced solid tumors.
Type de publicationJournal Article
Year of Publication2019
AuteursTeixeira L, Medioni J, Doucet L, Angelergues A, Culine S, Oudard S, Brizard M, Ghrieb Z, Adotevi O, Laheurte C, Durey M-ADragon, Laurent-Puig P, Kiladjian J-J, wain-Hobson S, Doppler V, DeFrance R, Garibal J, Huet T, Demoyen PLanglade
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.15_suppl.2642